Literature DB >> 1967596

Elevated frequency of a specific allele of the L-myc gene in male patients with bone and soft-tissue sarcomas.

M Kato1, J Toguchida, K Honda, M S Sasaki, M Ikenaga, M Sugimoto, T Yamaguchi, Y Kotoura, T Yamamuro, K Ishizaki.   

Abstract

Restriction fragment length polymorphisms (RFLPs) of 2 oncogenes, c-Ha-ras and L-myc, have been analyzed in 101 patients with bone and soft-tissue sarcoma and in 98 normal individuals. The c-Ha-ras gene was highly polymorphic both in sarcoma patients and in normal individuals. In contrast to our previous observation in breast cancer patients (Honda et al., 1988), no significant difference in allele frequencies between normal and sarcoma populations was observed. The L-myc locus revealed 2-allele polymorphism, allele L (10-kb) and S (6.6-kb), after digestion with Eco RI. The allele frequencies of L and S in sarcoma patients were 0.381 and 0.619, respectively, and those in normal individuals were 0.485 and 0.515, respectively. While the distributions of alleles in both populations fitted well with the Hardy-Weinberg equilibrium, the frequency of the S allele was significantly higher in sarcoma patients than in normal individuals (p less than 0.05). When sarcoma patients were divided into male and female subpopulations, this difference was highly significant only in males (p less than 0.01) but not in females. Our results suggest that males carrying the S allele may be prone to develop sarcoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967596     DOI: 10.1002/ijc.2910450110

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.

Authors:  I Zborovskaya; A Gasparian; M Kitaeva; B Polotzky; N Tupitzin; Z Machaladze; S Gerasimov; M Shtutman; M Jakubovskaya; M Davidov; A Tatosyan
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

2.  MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.

Authors:  K M Fong; Y Kida; P V Zimmerman; P J Smith
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

3.  L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.

Authors:  K Shibuta; H Inoue; K Sato; A Matsuyama; H Ueo; Y Tanaka; K Mafune; G F Barnard; M Mori
Journal:  Jpn J Cancer Res       Date:  2000-02

4.  Different susceptibility of each L-myc genotype to esophageal cancer risk factors.

Authors:  H Kumimoto; N Hamajima; K Nishizawa; Y Nishimoto; K Matsuo; H Harada; M Shinoda; S Hatooka; K Ishizaki
Journal:  Jpn J Cancer Res       Date:  2001-07

5.  Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.

Authors:  A Weston; N E Caporaso; L S Perrin; H Sugimura; S Tamai; T G Krontiris; B F Trump; R N Hoover; C C Harris
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

6.  Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.

Authors:  P E Crossen; M J Morrison; B M Colls
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.